Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolution Group PLS Regulatory News (FAN)

Share Price Information for Volution Group PLS (FAN)

Share Price is delayed by 15 minutes
Get Live Data
614.00    -5.00 (-0.81%)
Bid:
612.00
Ask:
614.00
Spread: 2.00 (0.327%)
Market Cap: £1.22b
FAN Live PriceLast checked at - London Stock Exchange

Intraday Volution Group PLS Share Chart

Trading Update

11 Aug 2017 07:00

RNS Number : 7182N
Volution Group plc
11 August 2017
 

 

 

Friday 11th August 2017

 

 

Volution Group plc

Trading Update

 Strong revenue growth of 20%; two acquisitions completed

 

 

Volution Group plc (LSE: FAN; "the Group" or "Volution"), a leading supplier of ventilation products to the residential and commercial construction markets, today announces a Trading Update, following the completion of its financial year on 31st July 2017.

 

The Group anticipates that results for the financial year 2017 will be in line with the Board's expectations.

Revenue in the 12 month period was £185 million, a 20% increase (15% on a constant currency basis) compared with the prior year. This comprised 7.6% organic growth (2.4% on a constant currency basis), with 13% the result of new acquisitions.

Organic growth was helped by a strong performance in the Nordics where revenue for the year grew by 5.1% on a constant currency basis and in our UK Residential New Build sector where revenue grew by 8.3%, along with continuing growth in the order book.

 

UK RMI trends improved compared to the first half of the year with full year growth of 8.6% (an organic decline of 3.7%). We were pleased with Private Residential RMI delivering organic growth of 1.6% in the second half of the year. UK Commercial revenue grew by 52% mainly as a result of acquisitions, with 1.1% organic growth. Exports from the UK grew 31%, 21% on a constant currency basis, helped by acquisitions and strong constant currency organic growth of 11%, mostly resulting from strong sales of our market leading heat recovery systems and fan coil units in Eire.

 

Revenue in Central Europe grew organically by 16% (1.7% on a constant currency basis) and Torin-Sifan (our OEM segment) grew organically during the year by 2.8% on a constant currency basis.

 

Volution also completed two acquisitions during the period which further broadened and strengthened our market and geographical diversity: Breathing Buildings in the UK (December 2016) and VoltAir System in Sweden (May 2017). Since acquisition, VoltAir System has delivered a significant project order intake. The integration of the acquisitions is progressing in line with our expectations and both businesses will be earnings enhancing in FY 2018.

 

Ronnie George, Chief Executive Officer of Volution Group plc, said:

 

"I am delighted with the progress that the Group has made during the year. The challenges in UK Residential RMI, most notably in the public sector, have continued in the year just ended but we have delivered good organic growth in our other market sectors. Private RMI returned to growth in the second half, underpinned by various sales and product initiatives with further developments underway for the 2018 financial year in both the public and private market sectors.

 

Integration of the two acquisitions in the year is progressing well, increasing our exposure to the new construction markets in both the Nordics and in the UK. Whilst uncertainty continues in the UK economy as a consequence of plans to leave the EU, our increasing market and geographical diversity gives us confidence for the year ahead."

 

The full year results for 2017 will be announced on 10th October 2017.

 

-Ends-

 

Enquiries:

 

 

Volution Group plc

 

Ronnie George, Chief Executive Officer

+44 (0) 1293 441501

Ian Dew, Chief Financial Officer

+44 (0) 1293 441536

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White

 

Matt Low

 

 

Note to Editors:

 

Volution Group plc (LSE: FAN) is a leading supplier of ventilation products to the residential and commercial construction markets in the UK, the Nordics and Central Europe.

 

The Volution Group operates through two divisions: the Ventilation Group and the OEM (Torin-Sifan) division. The Ventilation Group consists of 13 key brands - Vent-Axia, Manrose, Diffusion, National Ventilation, Airtech, Breathing Buildings, Fresh, PAX, VoltAir, Welair, inVENTer, Brüggemann and Ventilair, focused primarily on the UK, the Nordic and Central European ventilation markets. The Ventilation Group principally supplies ventilation products for residential and commercial ventilation applications. The OEM (Torin-Sifan) division supplies motors, fans and blowers to OEMs of heating and ventilation products for both residential and commercial construction applications in Europe.

For more information, please go to: www.volutiongroupplc.com

 

 

 

Cautionary statement regarding forward-looking statements

Certain statements made in this announcement may be forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of known and unknown risks and uncertainties that may cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. Persons receiving this announcement should not place undue reliance on forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, the Group does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKKDPABKDFFD
Date   Source Headline
12th Oct 202312:20 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSPreliminary Results for year ended 31 July 2023
3rd Oct 20236:15 pmRNSTotal Voting Rights
23rd Aug 20233:53 pmRNSHolding(s) in Company
16th Aug 20235:22 pmRNSHolding(s) in Company
1st Aug 20234:00 pmRNSTotal Voting Rights
20th Jul 20237:00 amRNSPre-close Trading Update
17th Jul 202310:00 amRNSNotice of Pre-close Trading Update
3rd Jul 20235:15 pmRNSTotal Voting Rights
27th Jun 20235:00 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSCompletion of Acquisition
19th Jun 20239:00 amRNSBoard Appointment
1st Jun 20234:30 pmRNSTotal Voting Rights
31st May 20231:30 pmRNSDirector Declaration
20th Apr 20237:00 amRNSAcquisitions Announcement
3rd Apr 202312:15 pmRNSTotal Voting Rights
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20231:36 pmRNSAppointment of Chair Designate
9th Mar 20237:00 amRNSHalf year Results
8th Mar 20233:50 pmRNSDirectorate Change
1st Mar 20234:30 pmRNSTotal Voting Rights
20th Feb 20231:00 pmRNSNotice of Interim Results
1st Feb 20234:00 pmRNSTotal Voting Rights
1st Feb 20233:45 pmRNSChange of Auditor
3rd Jan 20234:30 pmRNSTotal Voting Rights
14th Dec 20224:05 pmRNSResults of AGM
14th Dec 20227:00 amRNSAGM Trading Update
13th Dec 20223:00 pmRNSHolding(s) in Company
1st Dec 20224:05 pmRNSTotal Voting Rights
1st Nov 20224:00 pmRNSTotal Voting Rights
26th Oct 20228:45 amRNSDirector Declaration
21st Oct 20223:30 pmRNSAnnual Report 2022 & Notice of AGM
18th Oct 20224:30 pmRNSDirector/PDMR Shareholding
13th Oct 20222:30 pmRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSPreliminary Results for year ended 31 July 2022
1st Aug 20225:00 pmRNSTotal Voting Rights
21st Jul 20227:00 amRNSPre-close Trading Update
18th Jul 20229:15 amRNSNotice of Pre-close Trading Update
1st Jul 20224:30 pmRNSTotal Voting Rights
1st Jun 20224:20 pmRNSTotal Voting Rights
25th May 20227:00 amRNSTrading Update
21st Apr 20224:15 pmRNSHolding(s) in Company
1st Apr 20224:30 pmRNSTotal Voting Rights
11th Mar 20221:30 pmRNSShare Purchase by Chairman
10th Mar 20229:45 amRNSBoard Appointment
10th Mar 20227:00 amRNSHalf-year Report
21st Feb 202211:00 amRNSNotice of Interim Results
3rd Feb 20224:30 pmRNSHolding(s) in Company
2nd Feb 20224:30 pmRNSTotal Voting Rights
15th Dec 202112:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.